Abstract
The COVID-19 infection leads to profound changes in coagulation among patients affected by the disease. High prevalence of thrombotic events and its different clinical manifestations forced medical society to reevaluate the existent guidelines and to find the new applicable treatment approaches. This case study report includes a brief review of latest guidelines and scientific manuscripts, pathogenic justification of proposed treatment methods, an example of successful treatment of 56 years old male with acute limb ischemia, nonsmoker, with no previous history of peripheral arterial disease, severely affected by coronavirus infection. Ongoing pandemic makes the aspects of active surgical treatment of COVID-19 patients with associated thrombotic complications playing crucial role to decrease the number of negative consequences of infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
